Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Beckhove

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2014
Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of lifeK Steindorf, M E Schmidt, O Klassen, et al.
Carcinogenesis|October 23, 2019
Differential localization of PD-L1 and Akt-1 involvement in radioresistant and radiosensitive cell lines of head and neck squamous cell carcinomaD Schulz, M Streller, G Piendl, et al.
Cancer Letters|February 27, 2007
Potential target antigens for immunotherapy in human pancreatic cancerF H Schmitz-Winnenthal, L V Galindo-Escobedo, D Rimoldi, et al.
Pulmonology|April 13, 2024
Low tumor interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation studyS Safi, J Krzykalla, H Hoffmann, et al.
International Journal of Oncology|May 11, 2006
Specific immune recognition of pancreatic carcinoma by patient-derived CD4 and CD8 T cells and its improvement by interferon-gammaF H Schmitz-Winnenthal, L V Galindo Escobedo, P Beckhove, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2018
Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1G M Haag, I Zoernig, J C Hassel, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2014
Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of lifeK Steindorf, M E Schmidt, O Klassen, et al.
Carcinogenesis|October 23, 2019
Differential localization of PD-L1 and Akt-1 involvement in radioresistant and radiosensitive cell lines of head and neck squamous cell carcinomaD Schulz, M Streller, G Piendl, et al.
Cancer Letters|February 27, 2007
Potential target antigens for immunotherapy in human pancreatic cancerF H Schmitz-Winnenthal, L V Galindo-Escobedo, D Rimoldi, et al.
Pulmonology|April 13, 2024
Low tumor interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation studyS Safi, J Krzykalla, H Hoffmann, et al.
International Journal of Oncology|May 11, 2006
Specific immune recognition of pancreatic carcinoma by patient-derived CD4 and CD8 T cells and its improvement by interferon-gammaF H Schmitz-Winnenthal, L V Galindo Escobedo, P Beckhove, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2018
Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1G M Haag, I Zoernig, J C Hassel, et al.
Pageof 2